Novozymes’ ten-year high: Biosolutions drive double-digit growth in a volatile market

Related Articles

FormattedPicture

BUSINESS NEWS

The World Economic Forum (WEF) stresses that the two biggest challenges of our time can be tackled with biotech. The goal is to feed the growing human population with... Read More

FormattedPicture

BUSINESS NEWS

Chr. Hansen details the connections between the gut-brain axis and Irritable Bowel Syndrome (IBS) as well as the ability of some probiotics, like the company’s... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

NutritionInsight looks back at the biggest industry developments of the year. From the US infant formula shortage to rising inflation, it was a year filled with... Read More

FormattedPicture

BUSINESS NEWS

Enzymes manufacturer Novozymes has agreed to buy Chr. Hansen to expand in the nutrition industry. The merger resulted in a US$12.3 billion deal, writing history as the... Read More

FormattedPicture

BUSINESS NEWS

Bioscience players Novozymes and Chr. Hansen are merging in a deal that will result in the dissolution of the latter by the fourth quarter of 2023. The new company is... Read More

trans